nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—ABCB1—hematologic cancer	0.0798	1	CbGaD
Trazodone—ORM1—Imatinib—hematologic cancer	0.0348	0.0607	CbGbCtD
Trazodone—ABCB1—Lenalidomide—hematologic cancer	0.0171	0.0298	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.0164	0.0287	CbGbCtD
Trazodone—CYP3A7—Ifosfamide—hematologic cancer	0.0164	0.0287	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0157	0.0274	CbGbCtD
Trazodone—CYP3A7—Imatinib—hematologic cancer	0.0157	0.0274	CbGbCtD
Trazodone—CYP3A5—Daunorubicin—hematologic cancer	0.0154	0.0268	CbGbCtD
Trazodone—CYP2D6—Lomustine—hematologic cancer	0.015	0.0261	CbGbCtD
Trazodone—CYP3A5—Thalidomide—hematologic cancer	0.014	0.0244	CbGbCtD
Trazodone—CYP3A5—Teniposide—hematologic cancer	0.0134	0.0233	CbGbCtD
Trazodone—CYP2D6—Idarubicin—hematologic cancer	0.0133	0.0232	CbGbCtD
Trazodone—CYP3A5—Ifosfamide—hematologic cancer	0.0123	0.0215	CbGbCtD
Trazodone—CYP3A5—Imatinib—hematologic cancer	0.0118	0.0205	CbGbCtD
Trazodone—CYP2D6—Hydroxyurea—hematologic cancer	0.0113	0.0198	CbGbCtD
Trazodone—CYP3A4—Bexarotene—hematologic cancer	0.0102	0.0178	CbGbCtD
Trazodone—ABCB1—Daunorubicin—hematologic cancer	0.01	0.0175	CbGbCtD
Trazodone—CYP2D6—Bortezomib—hematologic cancer	0.00986	0.0172	CbGbCtD
Trazodone—CYP3A7—Irinotecan—hematologic cancer	0.00981	0.0171	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00981	0.0171	CbGbCtD
Trazodone—ABCB1—Alitretinoin—hematologic cancer	0.00981	0.0171	CbGbCtD
Trazodone—CYP3A4—Busulfan—hematologic cancer	0.00951	0.0166	CbGbCtD
Trazodone—CYP3A4—Lomustine—hematologic cancer	0.00951	0.0166	CbGbCtD
Trazodone—CYP3A5—Dasatinib—hematologic cancer	0.00946	0.0165	CbGbCtD
Trazodone—CYP3A7—Vincristine—hematologic cancer	0.00857	0.015	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00857	0.015	CbGbCtD
Trazodone—CYP3A4—Thiotepa—hematologic cancer	0.00848	0.0148	CbGbCtD
Trazodone—ABCB1—Imatinib—hematologic cancer	0.00767	0.0134	CbGbCtD
Trazodone—CYP3A5—Irinotecan—hematologic cancer	0.00736	0.0128	CbGbCtD
Trazodone—CYP2D6—Imatinib—hematologic cancer	0.00722	0.0126	CbGbCtD
Trazodone—ABCB1—Nilotinib—hematologic cancer	0.00697	0.0121	CbGbCtD
Trazodone—ABCB1—Vinorelbine—hematologic cancer	0.00691	0.012	CbGbCtD
Trazodone—CYP3A4—Methoxsalen—hematologic cancer	0.00659	0.0115	CbGbCtD
Trazodone—CYP2D6—Nilotinib—hematologic cancer	0.00657	0.0114	CbGbCtD
Trazodone—CYP2D6—Vinorelbine—hematologic cancer	0.00651	0.0114	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00646	0.0113	CbGbCtD
Trazodone—CYP3A7—Dexamethasone—hematologic cancer	0.00646	0.0113	CbGbCtD
Trazodone—CYP3A5—Vincristine—hematologic cancer	0.00643	0.0112	CbGbCtD
Trazodone—CYP3A4—Bortezomib—hematologic cancer	0.00627	0.0109	CbGbCtD
Trazodone—ABCB1—Dasatinib—hematologic cancer	0.00616	0.0107	CbGbCtD
Trazodone—ABCB1—Mitoxantrone—hematologic cancer	0.00608	0.0106	CbGbCtD
Trazodone—CYP3A4—Daunorubicin—hematologic cancer	0.006	0.0105	CbGbCtD
Trazodone—CYP3A5—Etoposide—hematologic cancer	0.00589	0.0103	CbGbCtD
Trazodone—ABCB1—Betamethasone—hematologic cancer	0.00542	0.00945	CbGbCtD
Trazodone—ABCB1—Gemcitabine—hematologic cancer	0.00537	0.00937	CbGbCtD
Trazodone—ABCB1—Prednisolone—hematologic cancer	0.00535	0.00933	CbGbCtD
Trazodone—CYP3A4—Cytarabine—hematologic cancer	0.00529	0.00922	CbGbCtD
Trazodone—CYP3A4—Teniposide—hematologic cancer	0.00521	0.00909	CbGbCtD
Trazodone—ABCB1—Prednisone—hematologic cancer	0.00505	0.00881	CbGbCtD
Trazodone—CYP3A5—Dexamethasone—hematologic cancer	0.00485	0.00845	CbGbCtD
Trazodone—CYP3A4—Ifosfamide—hematologic cancer	0.00481	0.00838	CbGbCtD
Trazodone—ABCB1—Irinotecan—hematologic cancer	0.00479	0.00835	CbGbCtD
Trazodone—CYP3A4—Imatinib—hematologic cancer	0.00459	0.00801	CbGbCtD
Trazodone—CYP3A4—Ruxolitinib—hematologic cancer	0.00433	0.00754	CbGbCtD
Trazodone—ABCB1—Vinblastine—hematologic cancer	0.00426	0.00742	CbGbCtD
Trazodone—ABCB1—Vincristine—hematologic cancer	0.00419	0.0073	CbGbCtD
Trazodone—CYP3A4—Nilotinib—hematologic cancer	0.00417	0.00728	CbGbCtD
Trazodone—CYP3A4—Vinorelbine—hematologic cancer	0.00414	0.00722	CbGbCtD
Trazodone—CYP2D6—Vinblastine—hematologic cancer	0.00401	0.007	CbGbCtD
Trazodone—ABCB1—Cisplatin—hematologic cancer	0.0039	0.00681	CbGbCtD
Trazodone—ABCB1—Etoposide—hematologic cancer	0.00384	0.00669	CbGbCtD
Trazodone—CYP3A4—Triamcinolone—hematologic cancer	0.00379	0.0066	CbGbCtD
Trazodone—CYP3A4—Dasatinib—hematologic cancer	0.00369	0.00643	CbGbCtD
Trazodone—CYP3A4—Mitoxantrone—hematologic cancer	0.00364	0.00635	CbGbCtD
Trazodone—CYP3A4—Betamethasone—hematologic cancer	0.00325	0.00566	CbGbCtD
Trazodone—CYP3A4—Prednisolone—hematologic cancer	0.00321	0.00559	CbGbCtD
Trazodone—ABCB1—Dexamethasone—hematologic cancer	0.00315	0.0055	CbGbCtD
Trazodone—CYP3A4—Prednisone—hematologic cancer	0.00303	0.00528	CbGbCtD
Trazodone—CYP2D6—Dexamethasone—hematologic cancer	0.00297	0.00518	CbGbCtD
Trazodone—CYP3A4—Irinotecan—hematologic cancer	0.00287	0.005	CbGbCtD
Trazodone—ABCB1—Doxorubicin—hematologic cancer	0.00262	0.00456	CbGbCtD
Trazodone—CYP3A4—Vinblastine—hematologic cancer	0.00255	0.00445	CbGbCtD
Trazodone—ABCB1—Methotrexate—hematologic cancer	0.00253	0.00442	CbGbCtD
Trazodone—CYP3A4—Vincristine—hematologic cancer	0.00251	0.00437	CbGbCtD
Trazodone—CYP2D6—Doxorubicin—hematologic cancer	0.00247	0.0043	CbGbCtD
Trazodone—CYP3A4—Etoposide—hematologic cancer	0.0023	0.00401	CbGbCtD
Trazodone—CYP3A4—Dexamethasone—hematologic cancer	0.00189	0.00329	CbGbCtD
Trazodone—CYP3A4—Doxorubicin—hematologic cancer	0.00157	0.00273	CbGbCtD
Trazodone—Ziprasidone—H1F0—hematologic cancer	0.000914	0.284	CrCbGaD
Trazodone—ORM1—hematopoietic system—hematologic cancer	0.000894	0.0563	CbGeAlD
Trazodone—SLC6A4—hematopoietic system—hematologic cancer	0.000761	0.048	CbGeAlD
Trazodone—Aripiprazole—H1F0—hematologic cancer	0.000714	0.222	CrCbGaD
Trazodone—HTR1A—hematopoietic system—hematologic cancer	0.000676	0.0426	CbGeAlD
Trazodone—ADRA1A—hematopoietic system—hematologic cancer	0.000623	0.0393	CbGeAlD
Trazodone—ORM1—blood—hematologic cancer	0.000592	0.0373	CbGeAlD
Trazodone—ORM1—bone marrow—hematologic cancer	0.000573	0.0361	CbGeAlD
Trazodone—ORM1—lung—hematologic cancer	0.000519	0.0327	CbGeAlD
Trazodone—SLC6A4—blood—hematologic cancer	0.000504	0.0318	CbGeAlD
Trazodone—HTR2B—blood—hematologic cancer	0.0005	0.0315	CbGeAlD
Trazodone—CYP3A5—hematopoietic system—hematologic cancer	0.000497	0.0313	CbGeAlD
Trazodone—HRH1—hematopoietic system—hematologic cancer	0.000482	0.0304	CbGeAlD
Trazodone—ADRA2A—hematopoietic system—hematologic cancer	0.000474	0.0299	CbGeAlD
Trazodone—Quetiapine—H1F0—hematologic cancer	0.000446	0.139	CrCbGaD
Trazodone—SLC6A4—lung—hematologic cancer	0.000442	0.0279	CbGeAlD
Trazodone—HTR2B—lung—hematologic cancer	0.000438	0.0276	CbGeAlD
Trazodone—ADRA1A—blood—hematologic cancer	0.000413	0.026	CbGeAlD
Trazodone—HTR2A—hematopoietic system—hematologic cancer	0.000403	0.0254	CbGeAlD
Trazodone—Clozapine—H1F0—hematologic cancer	0.000384	0.119	CrCbGaD
Trazodone—CYP3A4—hematopoietic system—hematologic cancer	0.000373	0.0235	CbGeAlD
Trazodone—CYP2D6—hematopoietic system—hematologic cancer	0.000367	0.0231	CbGeAlD
Trazodone—ADRA2A—gonad—hematologic cancer	0.00036	0.0227	CbGeAlD
Trazodone—ORM1—lymph node—hematologic cancer	0.000355	0.0224	CbGeAlD
Trazodone—CYP3A5—blood—hematologic cancer	0.000329	0.0207	CbGeAlD
Trazodone—ADRA2A—blood—hematologic cancer	0.000314	0.0198	CbGeAlD
Trazodone—HTR2A—gonad—hematologic cancer	0.000306	0.0193	CbGeAlD
Trazodone—HTR2B—lymph node—hematologic cancer	0.0003	0.0189	CbGeAlD
Trazodone—CYP3A5—lung—hematologic cancer	0.000289	0.0182	CbGeAlD
Trazodone—HRH1—lung—hematologic cancer	0.00028	0.0177	CbGeAlD
Trazodone—ADRA2A—lung—hematologic cancer	0.000275	0.0173	CbGeAlD
Trazodone—HTR2A—blood—hematologic cancer	0.000267	0.0168	CbGeAlD
Trazodone—HRH1—testis—hematologic cancer	0.000264	0.0167	CbGeAlD
Trazodone—ABCB1—hematopoietic system—hematologic cancer	0.000264	0.0166	CbGeAlD
Trazodone—ADRA2A—testis—hematologic cancer	0.00026	0.0164	CbGeAlD
Trazodone—CYP3A4—blood—hematologic cancer	0.000247	0.0156	CbGeAlD
Trazodone—CYP2D6—blood—hematologic cancer	0.000243	0.0153	CbGeAlD
Trazodone—Thioproperazine—SLC22A1—hematologic cancer	0.000241	0.0749	CrCbGaD
Trazodone—HTR2A—lung—hematologic cancer	0.000234	0.0147	CbGeAlD
Trazodone—HTR2A—testis—hematologic cancer	0.000221	0.0139	CbGeAlD
Trazodone—CYP2D6—testis—hematologic cancer	0.000201	0.0127	CbGeAlD
Trazodone—ABCB1—gonad—hematologic cancer	0.000201	0.0126	CbGeAlD
Trazodone—HRH1—lymph node—hematologic cancer	0.000192	0.0121	CbGeAlD
Trazodone—ADRA2A—lymph node—hematologic cancer	0.000188	0.0119	CbGeAlD
Trazodone—ABCB1—blood—hematologic cancer	0.000175	0.011	CbGeAlD
Trazodone—ABCB1—bone marrow—hematologic cancer	0.000169	0.0107	CbGeAlD
Trazodone—ABCB1—lung—hematologic cancer	0.000153	0.00966	CbGeAlD
Trazodone—ABCB1—testis—hematologic cancer	0.000145	0.00912	CbGeAlD
Trazodone—ABCB1—lymph node—hematologic cancer	0.000105	0.00661	CbGeAlD
Trazodone—Domperidone—ABCB1—hematologic cancer	9.56e-05	0.0297	CrCbGaD
Trazodone—Nefazodone—ABCB1—hematologic cancer	7.94e-05	0.0247	CrCbGaD
Trazodone—Aripiprazole—ABCB1—hematologic cancer	7.38e-05	0.023	CrCbGaD
Trazodone—Thioproperazine—ALB—hematologic cancer	7.33e-05	0.0228	CrCbGaD
Trazodone—Fluphenazine—ABCB1—hematologic cancer	5.95e-05	0.0185	CrCbGaD
Trazodone—Trifluoperazine—ABCB1—hematologic cancer	4.76e-05	0.0148	CrCbGaD
Trazodone—Quetiapine—ABCB1—hematologic cancer	4.61e-05	0.0143	CrCbGaD
Trazodone—Clozapine—ABCB1—hematologic cancer	3.97e-05	0.0123	CrCbGaD
Trazodone—Hypersensitivity—Etoposide—hematologic cancer	2.91e-05	0.000112	CcSEcCtD
Trazodone—Tinnitus—Epirubicin—hematologic cancer	2.9e-05	0.000112	CcSEcCtD
Trazodone—Headache—Gemcitabine—hematologic cancer	2.89e-05	0.000112	CcSEcCtD
Trazodone—Nausea—Vincristine—hematologic cancer	2.89e-05	0.000111	CcSEcCtD
Trazodone—Flushing—Epirubicin—hematologic cancer	2.89e-05	0.000111	CcSEcCtD
Trazodone—Hypersensitivity—Prednisolone—hematologic cancer	2.87e-05	0.00011	CcSEcCtD
Trazodone—Hypoaesthesia—Doxorubicin—hematologic cancer	2.87e-05	0.00011	CcSEcCtD
Trazodone—Urticaria—Triamcinolone—hematologic cancer	2.84e-05	0.00011	CcSEcCtD
Trazodone—Dysgeusia—Methotrexate—hematologic cancer	2.84e-05	0.000109	CcSEcCtD
Trazodone—Asthenia—Etoposide—hematologic cancer	2.83e-05	0.000109	CcSEcCtD
Trazodone—Body temperature increased—Triamcinolone—hematologic cancer	2.83e-05	0.000109	CcSEcCtD
Trazodone—Oedema—Prednisone—hematologic cancer	2.83e-05	0.000109	CcSEcCtD
Trazodone—Decreased appetite—Betamethasone—hematologic cancer	2.82e-05	0.000109	CcSEcCtD
Trazodone—Decreased appetite—Dexamethasone—hematologic cancer	2.82e-05	0.000109	CcSEcCtD
Trazodone—Nausea—Irinotecan—hematologic cancer	2.82e-05	0.000109	CcSEcCtD
Trazodone—Nausea—Mitoxantrone—hematologic cancer	2.82e-05	0.000109	CcSEcCtD
Trazodone—Back pain—Methotrexate—hematologic cancer	2.8e-05	0.000108	CcSEcCtD
Trazodone—Fatigue—Dexamethasone—hematologic cancer	2.8e-05	0.000108	CcSEcCtD
Trazodone—Fatigue—Betamethasone—hematologic cancer	2.8e-05	0.000108	CcSEcCtD
Trazodone—Chills—Epirubicin—hematologic cancer	2.79e-05	0.000108	CcSEcCtD
Trazodone—Pruritus—Etoposide—hematologic cancer	2.79e-05	0.000108	CcSEcCtD
Trazodone—Shock—Prednisone—hematologic cancer	2.78e-05	0.000107	CcSEcCtD
Trazodone—Arrhythmia—Epirubicin—hematologic cancer	2.78e-05	0.000107	CcSEcCtD
Trazodone—Pain—Dexamethasone—hematologic cancer	2.78e-05	0.000107	CcSEcCtD
Trazodone—Pain—Betamethasone—hematologic cancer	2.78e-05	0.000107	CcSEcCtD
Trazodone—Visual impairment—Doxorubicin—hematologic cancer	2.78e-05	0.000107	CcSEcCtD
Trazodone—Tachycardia—Prednisone—hematologic cancer	2.76e-05	0.000106	CcSEcCtD
Trazodone—Alopecia—Epirubicin—hematologic cancer	2.75e-05	0.000106	CcSEcCtD
Trazodone—Nausea—Gemcitabine—hematologic cancer	2.74e-05	0.000106	CcSEcCtD
Trazodone—Vomiting—Cisplatin—hematologic cancer	2.74e-05	0.000106	CcSEcCtD
Trazodone—Hyperhidrosis—Prednisone—hematologic cancer	2.73e-05	0.000105	CcSEcCtD
Trazodone—Vision blurred—Methotrexate—hematologic cancer	2.73e-05	0.000105	CcSEcCtD
Trazodone—Rash—Cisplatin—hematologic cancer	2.72e-05	0.000105	CcSEcCtD
Trazodone—Dermatitis—Cisplatin—hematologic cancer	2.71e-05	0.000105	CcSEcCtD
Trazodone—Diarrhoea—Etoposide—hematologic cancer	2.7e-05	0.000104	CcSEcCtD
Trazodone—Anorexia—Prednisone—hematologic cancer	2.7e-05	0.000104	CcSEcCtD
Trazodone—Ill-defined disorder—Methotrexate—hematologic cancer	2.69e-05	0.000104	CcSEcCtD
Trazodone—Tinnitus—Doxorubicin—hematologic cancer	2.69e-05	0.000103	CcSEcCtD
Trazodone—Anaemia—Methotrexate—hematologic cancer	2.68e-05	0.000103	CcSEcCtD
Trazodone—Feeling abnormal—Betamethasone—hematologic cancer	2.68e-05	0.000103	CcSEcCtD
Trazodone—Feeling abnormal—Dexamethasone—hematologic cancer	2.68e-05	0.000103	CcSEcCtD
Trazodone—Flushing—Doxorubicin—hematologic cancer	2.67e-05	0.000103	CcSEcCtD
Trazodone—Flatulence—Epirubicin—hematologic cancer	2.67e-05	0.000103	CcSEcCtD
Trazodone—Tension—Epirubicin—hematologic cancer	2.66e-05	0.000102	CcSEcCtD
Trazodone—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.66e-05	0.000102	CcSEcCtD
Trazodone—Gastrointestinal pain—Betamethasone—hematologic cancer	2.66e-05	0.000102	CcSEcCtD
Trazodone—Dysgeusia—Epirubicin—hematologic cancer	2.65e-05	0.000102	CcSEcCtD
Trazodone—Hypersensitivity—Triamcinolone—hematologic cancer	2.64e-05	0.000102	CcSEcCtD
Trazodone—Nervousness—Epirubicin—hematologic cancer	2.63e-05	0.000101	CcSEcCtD
Trazodone—Back pain—Epirubicin—hematologic cancer	2.62e-05	0.000101	CcSEcCtD
Trazodone—Malaise—Methotrexate—hematologic cancer	2.61e-05	0.000101	CcSEcCtD
Trazodone—Dizziness—Etoposide—hematologic cancer	2.61e-05	0.000101	CcSEcCtD
Trazodone—Vertigo—Methotrexate—hematologic cancer	2.6e-05	0.0001	CcSEcCtD
Trazodone—Chills—Doxorubicin—hematologic cancer	2.58e-05	9.96e-05	CcSEcCtD
Trazodone—Urticaria—Betamethasone—hematologic cancer	2.58e-05	9.94e-05	CcSEcCtD
Trazodone—Urticaria—Dexamethasone—hematologic cancer	2.58e-05	9.94e-05	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.58e-05	9.93e-05	CcSEcCtD
Trazodone—Dizziness—Prednisolone—hematologic cancer	2.57e-05	9.92e-05	CcSEcCtD
Trazodone—Arrhythmia—Doxorubicin—hematologic cancer	2.57e-05	9.92e-05	CcSEcCtD
Trazodone—Asthenia—Triamcinolone—hematologic cancer	2.57e-05	9.9e-05	CcSEcCtD
Trazodone—Abdominal pain—Betamethasone—hematologic cancer	2.57e-05	9.89e-05	CcSEcCtD
Trazodone—Abdominal pain—Dexamethasone—hematologic cancer	2.57e-05	9.89e-05	CcSEcCtD
Trazodone—Body temperature increased—Dexamethasone—hematologic cancer	2.57e-05	9.89e-05	CcSEcCtD
Trazodone—Body temperature increased—Betamethasone—hematologic cancer	2.57e-05	9.89e-05	CcSEcCtD
Trazodone—Nausea—Cisplatin—hematologic cancer	2.56e-05	9.86e-05	CcSEcCtD
Trazodone—Insomnia—Prednisone—hematologic cancer	2.56e-05	9.86e-05	CcSEcCtD
Trazodone—Vision blurred—Epirubicin—hematologic cancer	2.55e-05	9.84e-05	CcSEcCtD
Trazodone—Alopecia—Doxorubicin—hematologic cancer	2.55e-05	9.81e-05	CcSEcCtD
Trazodone—Paraesthesia—Prednisone—hematologic cancer	2.54e-05	9.79e-05	CcSEcCtD
Trazodone—Pruritus—Triamcinolone—hematologic cancer	2.53e-05	9.76e-05	CcSEcCtD
Trazodone—Ill-defined disorder—Epirubicin—hematologic cancer	2.51e-05	9.69e-05	CcSEcCtD
Trazodone—Vomiting—Etoposide—hematologic cancer	2.51e-05	9.67e-05	CcSEcCtD
Trazodone—Anaemia—Epirubicin—hematologic cancer	2.5e-05	9.65e-05	CcSEcCtD
Trazodone—Agitation—Epirubicin—hematologic cancer	2.49e-05	9.6e-05	CcSEcCtD
Trazodone—Rash—Etoposide—hematologic cancer	2.49e-05	9.59e-05	CcSEcCtD
Trazodone—Dermatitis—Etoposide—hematologic cancer	2.49e-05	9.58e-05	CcSEcCtD
Trazodone—Headache—Etoposide—hematologic cancer	2.47e-05	9.53e-05	CcSEcCtD
Trazodone—Flatulence—Doxorubicin—hematologic cancer	2.47e-05	9.52e-05	CcSEcCtD
Trazodone—Arthralgia—Methotrexate—hematologic cancer	2.47e-05	9.5e-05	CcSEcCtD
Trazodone—Chest pain—Methotrexate—hematologic cancer	2.47e-05	9.5e-05	CcSEcCtD
Trazodone—Myalgia—Methotrexate—hematologic cancer	2.47e-05	9.5e-05	CcSEcCtD
Trazodone—Tension—Doxorubicin—hematologic cancer	2.46e-05	9.48e-05	CcSEcCtD
Trazodone—Decreased appetite—Prednisone—hematologic cancer	2.46e-05	9.47e-05	CcSEcCtD
Trazodone—Dysgeusia—Doxorubicin—hematologic cancer	2.46e-05	9.46e-05	CcSEcCtD
Trazodone—Rash—Prednisolone—hematologic cancer	2.45e-05	9.46e-05	CcSEcCtD
Trazodone—Dermatitis—Prednisolone—hematologic cancer	2.45e-05	9.45e-05	CcSEcCtD
Trazodone—Malaise—Epirubicin—hematologic cancer	2.44e-05	9.42e-05	CcSEcCtD
Trazodone—Fatigue—Prednisone—hematologic cancer	2.44e-05	9.4e-05	CcSEcCtD
Trazodone—Headache—Prednisolone—hematologic cancer	2.44e-05	9.4e-05	CcSEcCtD
Trazodone—Discomfort—Methotrexate—hematologic cancer	2.44e-05	9.39e-05	CcSEcCtD
Trazodone—Nervousness—Doxorubicin—hematologic cancer	2.44e-05	9.39e-05	CcSEcCtD
Trazodone—Vertigo—Epirubicin—hematologic cancer	2.43e-05	9.38e-05	CcSEcCtD
Trazodone—Syncope—Epirubicin—hematologic cancer	2.43e-05	9.37e-05	CcSEcCtD
Trazodone—Back pain—Doxorubicin—hematologic cancer	2.43e-05	9.35e-05	CcSEcCtD
Trazodone—Constipation—Prednisone—hematologic cancer	2.42e-05	9.32e-05	CcSEcCtD
Trazodone—Palpitations—Epirubicin—hematologic cancer	2.39e-05	9.23e-05	CcSEcCtD
Trazodone—Confusional state—Methotrexate—hematologic cancer	2.38e-05	9.18e-05	CcSEcCtD
Trazodone—Loss of consciousness—Epirubicin—hematologic cancer	2.38e-05	9.18e-05	CcSEcCtD
Trazodone—Dizziness—Triamcinolone—hematologic cancer	2.37e-05	9.12e-05	CcSEcCtD
Trazodone—Vision blurred—Doxorubicin—hematologic cancer	2.36e-05	9.11e-05	CcSEcCtD
Trazodone—Nausea—Etoposide—hematologic cancer	2.34e-05	9.03e-05	CcSEcCtD
Trazodone—Hypertension—Epirubicin—hematologic cancer	2.34e-05	9.02e-05	CcSEcCtD
Trazodone—Feeling abnormal—Prednisone—hematologic cancer	2.33e-05	8.98e-05	CcSEcCtD
Trazodone—Asthenia—Betamethasone—hematologic cancer	2.33e-05	8.98e-05	CcSEcCtD
Trazodone—Asthenia—Dexamethasone—hematologic cancer	2.33e-05	8.98e-05	CcSEcCtD
Trazodone—Ill-defined disorder—Doxorubicin—hematologic cancer	2.33e-05	8.97e-05	CcSEcCtD
Trazodone—Anaemia—Doxorubicin—hematologic cancer	2.32e-05	8.93e-05	CcSEcCtD
Trazodone—Gastrointestinal pain—Prednisone—hematologic cancer	2.31e-05	8.91e-05	CcSEcCtD
Trazodone—Nausea—Prednisolone—hematologic cancer	2.31e-05	8.91e-05	CcSEcCtD
Trazodone—Chest pain—Epirubicin—hematologic cancer	2.31e-05	8.89e-05	CcSEcCtD
Trazodone—Arthralgia—Epirubicin—hematologic cancer	2.31e-05	8.89e-05	CcSEcCtD
Trazodone—Myalgia—Epirubicin—hematologic cancer	2.31e-05	8.89e-05	CcSEcCtD
Trazodone—Agitation—Doxorubicin—hematologic cancer	2.3e-05	8.88e-05	CcSEcCtD
Trazodone—Anxiety—Epirubicin—hematologic cancer	2.3e-05	8.86e-05	CcSEcCtD
Trazodone—Pruritus—Betamethasone—hematologic cancer	2.3e-05	8.85e-05	CcSEcCtD
Trazodone—Pruritus—Dexamethasone—hematologic cancer	2.3e-05	8.85e-05	CcSEcCtD
Trazodone—Hyperhidrosis—Methotrexate—hematologic cancer	2.28e-05	8.8e-05	CcSEcCtD
Trazodone—Discomfort—Epirubicin—hematologic cancer	2.28e-05	8.78e-05	CcSEcCtD
Trazodone—Vomiting—Triamcinolone—hematologic cancer	2.28e-05	8.77e-05	CcSEcCtD
Trazodone—Malaise—Doxorubicin—hematologic cancer	2.26e-05	8.71e-05	CcSEcCtD
Trazodone—Rash—Triamcinolone—hematologic cancer	2.26e-05	8.7e-05	CcSEcCtD
Trazodone—Dry mouth—Epirubicin—hematologic cancer	2.26e-05	8.7e-05	CcSEcCtD
Trazodone—Dermatitis—Triamcinolone—hematologic cancer	2.25e-05	8.69e-05	CcSEcCtD
Trazodone—Vertigo—Doxorubicin—hematologic cancer	2.25e-05	8.68e-05	CcSEcCtD
Trazodone—Anorexia—Methotrexate—hematologic cancer	2.25e-05	8.68e-05	CcSEcCtD
Trazodone—Syncope—Doxorubicin—hematologic cancer	2.25e-05	8.67e-05	CcSEcCtD
Trazodone—Urticaria—Prednisone—hematologic cancer	2.25e-05	8.66e-05	CcSEcCtD
Trazodone—Headache—Triamcinolone—hematologic cancer	2.24e-05	8.64e-05	CcSEcCtD
Trazodone—Abdominal pain—Prednisone—hematologic cancer	2.24e-05	8.62e-05	CcSEcCtD
Trazodone—Body temperature increased—Prednisone—hematologic cancer	2.24e-05	8.62e-05	CcSEcCtD
Trazodone—Confusional state—Epirubicin—hematologic cancer	2.23e-05	8.59e-05	CcSEcCtD
Trazodone—Diarrhoea—Dexamethasone—hematologic cancer	2.22e-05	8.56e-05	CcSEcCtD
Trazodone—Diarrhoea—Betamethasone—hematologic cancer	2.22e-05	8.56e-05	CcSEcCtD
Trazodone—Palpitations—Doxorubicin—hematologic cancer	2.22e-05	8.54e-05	CcSEcCtD
Trazodone—Oedema—Epirubicin—hematologic cancer	2.21e-05	8.52e-05	CcSEcCtD
Trazodone—Hypotension—Methotrexate—hematologic cancer	2.21e-05	8.51e-05	CcSEcCtD
Trazodone—Loss of consciousness—Doxorubicin—hematologic cancer	2.2e-05	8.49e-05	CcSEcCtD
Trazodone—Shock—Epirubicin—hematologic cancer	2.18e-05	8.39e-05	CcSEcCtD
Trazodone—Hypertension—Doxorubicin—hematologic cancer	2.16e-05	8.34e-05	CcSEcCtD
Trazodone—Tachycardia—Epirubicin—hematologic cancer	2.16e-05	8.32e-05	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.15e-05	8.3e-05	CcSEcCtD
Trazodone—Dizziness—Betamethasone—hematologic cancer	2.15e-05	8.28e-05	CcSEcCtD
Trazodone—Dizziness—Dexamethasone—hematologic cancer	2.15e-05	8.28e-05	CcSEcCtD
Trazodone—Hyperhidrosis—Epirubicin—hematologic cancer	2.14e-05	8.24e-05	CcSEcCtD
Trazodone—Insomnia—Methotrexate—hematologic cancer	2.14e-05	8.24e-05	CcSEcCtD
Trazodone—Myalgia—Doxorubicin—hematologic cancer	2.13e-05	8.23e-05	CcSEcCtD
Trazodone—Arthralgia—Doxorubicin—hematologic cancer	2.13e-05	8.23e-05	CcSEcCtD
Trazodone—Chest pain—Doxorubicin—hematologic cancer	2.13e-05	8.23e-05	CcSEcCtD
Trazodone—Anxiety—Doxorubicin—hematologic cancer	2.13e-05	8.2e-05	CcSEcCtD
Trazodone—Nausea—Triamcinolone—hematologic cancer	2.13e-05	8.19e-05	CcSEcCtD
Trazodone—Paraesthesia—Methotrexate—hematologic cancer	2.12e-05	8.18e-05	CcSEcCtD
Trazodone—Discomfort—Doxorubicin—hematologic cancer	2.11e-05	8.13e-05	CcSEcCtD
Trazodone—Anorexia—Epirubicin—hematologic cancer	2.11e-05	8.12e-05	CcSEcCtD
Trazodone—Dyspnoea—Methotrexate—hematologic cancer	2.11e-05	8.12e-05	CcSEcCtD
Trazodone—Somnolence—Methotrexate—hematologic cancer	2.1e-05	8.1e-05	CcSEcCtD
Trazodone—Dry mouth—Doxorubicin—hematologic cancer	2.09e-05	8.05e-05	CcSEcCtD
Trazodone—Hypersensitivity—Prednisone—hematologic cancer	2.08e-05	8.03e-05	CcSEcCtD
Trazodone—Hypotension—Epirubicin—hematologic cancer	2.07e-05	7.96e-05	CcSEcCtD
Trazodone—Vomiting—Dexamethasone—hematologic cancer	2.06e-05	7.96e-05	CcSEcCtD
Trazodone—Vomiting—Betamethasone—hematologic cancer	2.06e-05	7.96e-05	CcSEcCtD
Trazodone—Confusional state—Doxorubicin—hematologic cancer	2.06e-05	7.95e-05	CcSEcCtD
Trazodone—Decreased appetite—Methotrexate—hematologic cancer	2.05e-05	7.92e-05	CcSEcCtD
Trazodone—Rash—Betamethasone—hematologic cancer	2.05e-05	7.89e-05	CcSEcCtD
Trazodone—Rash—Dexamethasone—hematologic cancer	2.05e-05	7.89e-05	CcSEcCtD
Trazodone—Oedema—Doxorubicin—hematologic cancer	2.05e-05	7.89e-05	CcSEcCtD
Trazodone—Dermatitis—Betamethasone—hematologic cancer	2.05e-05	7.88e-05	CcSEcCtD
Trazodone—Dermatitis—Dexamethasone—hematologic cancer	2.05e-05	7.88e-05	CcSEcCtD
Trazodone—Fatigue—Methotrexate—hematologic cancer	2.04e-05	7.85e-05	CcSEcCtD
Trazodone—Headache—Betamethasone—hematologic cancer	2.03e-05	7.84e-05	CcSEcCtD
Trazodone—Headache—Dexamethasone—hematologic cancer	2.03e-05	7.84e-05	CcSEcCtD
Trazodone—Asthenia—Prednisone—hematologic cancer	2.03e-05	7.82e-05	CcSEcCtD
Trazodone—Pain—Methotrexate—hematologic cancer	2.02e-05	7.79e-05	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.01e-05	7.77e-05	CcSEcCtD
Trazodone—Shock—Doxorubicin—hematologic cancer	2.01e-05	7.76e-05	CcSEcCtD
Trazodone—Pruritus—Prednisone—hematologic cancer	2e-05	7.71e-05	CcSEcCtD
Trazodone—Insomnia—Epirubicin—hematologic cancer	2e-05	7.71e-05	CcSEcCtD
Trazodone—Tachycardia—Doxorubicin—hematologic cancer	2e-05	7.7e-05	CcSEcCtD
Trazodone—Paraesthesia—Epirubicin—hematologic cancer	1.99e-05	7.65e-05	CcSEcCtD
Trazodone—Hyperhidrosis—Doxorubicin—hematologic cancer	1.98e-05	7.62e-05	CcSEcCtD
Trazodone—Dyspnoea—Epirubicin—hematologic cancer	1.97e-05	7.6e-05	CcSEcCtD
Trazodone—Somnolence—Epirubicin—hematologic cancer	1.97e-05	7.58e-05	CcSEcCtD
Trazodone—Anorexia—Doxorubicin—hematologic cancer	1.95e-05	7.52e-05	CcSEcCtD
Trazodone—Feeling abnormal—Methotrexate—hematologic cancer	1.95e-05	7.51e-05	CcSEcCtD
Trazodone—Diarrhoea—Prednisone—hematologic cancer	1.93e-05	7.46e-05	CcSEcCtD
Trazodone—Gastrointestinal pain—Methotrexate—hematologic cancer	1.93e-05	7.45e-05	CcSEcCtD
Trazodone—Nausea—Dexamethasone—hematologic cancer	1.93e-05	7.43e-05	CcSEcCtD
Trazodone—Nausea—Betamethasone—hematologic cancer	1.93e-05	7.43e-05	CcSEcCtD
Trazodone—Decreased appetite—Epirubicin—hematologic cancer	1.92e-05	7.41e-05	CcSEcCtD
Trazodone—Hypotension—Doxorubicin—hematologic cancer	1.91e-05	7.37e-05	CcSEcCtD
Trazodone—Fatigue—Epirubicin—hematologic cancer	1.91e-05	7.35e-05	CcSEcCtD
Trazodone—Pain—Epirubicin—hematologic cancer	1.89e-05	7.29e-05	CcSEcCtD
Trazodone—Constipation—Epirubicin—hematologic cancer	1.89e-05	7.29e-05	CcSEcCtD
Trazodone—Urticaria—Methotrexate—hematologic cancer	1.88e-05	7.24e-05	CcSEcCtD
Trazodone—Dizziness—Prednisone—hematologic cancer	1.87e-05	7.21e-05	CcSEcCtD
Trazodone—Body temperature increased—Methotrexate—hematologic cancer	1.87e-05	7.2e-05	CcSEcCtD
Trazodone—Abdominal pain—Methotrexate—hematologic cancer	1.87e-05	7.2e-05	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.86e-05	7.19e-05	CcSEcCtD
Trazodone—Insomnia—Doxorubicin—hematologic cancer	1.85e-05	7.13e-05	CcSEcCtD
Trazodone—Paraesthesia—Doxorubicin—hematologic cancer	1.84e-05	7.08e-05	CcSEcCtD
Trazodone—Dyspnoea—Doxorubicin—hematologic cancer	1.82e-05	7.03e-05	CcSEcCtD
Trazodone—Feeling abnormal—Epirubicin—hematologic cancer	1.82e-05	7.02e-05	CcSEcCtD
Trazodone—Somnolence—Doxorubicin—hematologic cancer	1.82e-05	7.01e-05	CcSEcCtD
Trazodone—Gastrointestinal pain—Epirubicin—hematologic cancer	1.81e-05	6.97e-05	CcSEcCtD
Trazodone—Vomiting—Prednisone—hematologic cancer	1.8e-05	6.93e-05	CcSEcCtD
Trazodone—Rash—Prednisone—hematologic cancer	1.78e-05	6.87e-05	CcSEcCtD
Trazodone—Dermatitis—Prednisone—hematologic cancer	1.78e-05	6.87e-05	CcSEcCtD
Trazodone—Decreased appetite—Doxorubicin—hematologic cancer	1.78e-05	6.86e-05	CcSEcCtD
Trazodone—Headache—Prednisone—hematologic cancer	1.77e-05	6.83e-05	CcSEcCtD
Trazodone—Fatigue—Doxorubicin—hematologic cancer	1.76e-05	6.8e-05	CcSEcCtD
Trazodone—Urticaria—Epirubicin—hematologic cancer	1.76e-05	6.77e-05	CcSEcCtD
Trazodone—Constipation—Doxorubicin—hematologic cancer	1.75e-05	6.74e-05	CcSEcCtD
Trazodone—Pain—Doxorubicin—hematologic cancer	1.75e-05	6.74e-05	CcSEcCtD
Trazodone—Body temperature increased—Epirubicin—hematologic cancer	1.75e-05	6.74e-05	CcSEcCtD
Trazodone—Abdominal pain—Epirubicin—hematologic cancer	1.75e-05	6.74e-05	CcSEcCtD
Trazodone—Hypersensitivity—Methotrexate—hematologic cancer	1.74e-05	6.71e-05	CcSEcCtD
Trazodone—Asthenia—Methotrexate—hematologic cancer	1.7e-05	6.53e-05	CcSEcCtD
Trazodone—Feeling abnormal—Doxorubicin—hematologic cancer	1.69e-05	6.5e-05	CcSEcCtD
Trazodone—Nausea—Prednisone—hematologic cancer	1.68e-05	6.47e-05	CcSEcCtD
Trazodone—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.67e-05	6.45e-05	CcSEcCtD
Trazodone—Pruritus—Methotrexate—hematologic cancer	1.67e-05	6.44e-05	CcSEcCtD
Trazodone—Hypersensitivity—Epirubicin—hematologic cancer	1.63e-05	6.28e-05	CcSEcCtD
Trazodone—Urticaria—Doxorubicin—hematologic cancer	1.63e-05	6.27e-05	CcSEcCtD
Trazodone—Abdominal pain—Doxorubicin—hematologic cancer	1.62e-05	6.23e-05	CcSEcCtD
Trazodone—Body temperature increased—Doxorubicin—hematologic cancer	1.62e-05	6.23e-05	CcSEcCtD
Trazodone—Diarrhoea—Methotrexate—hematologic cancer	1.62e-05	6.23e-05	CcSEcCtD
Trazodone—Asthenia—Epirubicin—hematologic cancer	1.59e-05	6.12e-05	CcSEcCtD
Trazodone—Pruritus—Epirubicin—hematologic cancer	1.56e-05	6.03e-05	CcSEcCtD
Trazodone—Dizziness—Methotrexate—hematologic cancer	1.56e-05	6.02e-05	CcSEcCtD
Trazodone—Diarrhoea—Epirubicin—hematologic cancer	1.51e-05	5.83e-05	CcSEcCtD
Trazodone—Hypersensitivity—Doxorubicin—hematologic cancer	1.51e-05	5.81e-05	CcSEcCtD
Trazodone—Vomiting—Methotrexate—hematologic cancer	1.5e-05	5.79e-05	CcSEcCtD
Trazodone—Rash—Methotrexate—hematologic cancer	1.49e-05	5.74e-05	CcSEcCtD
Trazodone—Dermatitis—Methotrexate—hematologic cancer	1.49e-05	5.74e-05	CcSEcCtD
Trazodone—Headache—Methotrexate—hematologic cancer	1.48e-05	5.71e-05	CcSEcCtD
Trazodone—Asthenia—Doxorubicin—hematologic cancer	1.47e-05	5.66e-05	CcSEcCtD
Trazodone—Dizziness—Epirubicin—hematologic cancer	1.46e-05	5.64e-05	CcSEcCtD
Trazodone—Pruritus—Doxorubicin—hematologic cancer	1.45e-05	5.58e-05	CcSEcCtD
Trazodone—Vomiting—Epirubicin—hematologic cancer	1.41e-05	5.42e-05	CcSEcCtD
Trazodone—Nausea—Methotrexate—hematologic cancer	1.4e-05	5.41e-05	CcSEcCtD
Trazodone—Diarrhoea—Doxorubicin—hematologic cancer	1.4e-05	5.4e-05	CcSEcCtD
Trazodone—Rash—Epirubicin—hematologic cancer	1.39e-05	5.37e-05	CcSEcCtD
Trazodone—Dermatitis—Epirubicin—hematologic cancer	1.39e-05	5.37e-05	CcSEcCtD
Trazodone—Headache—Epirubicin—hematologic cancer	1.39e-05	5.34e-05	CcSEcCtD
Trazodone—Dizziness—Doxorubicin—hematologic cancer	1.35e-05	5.22e-05	CcSEcCtD
Trazodone—Nausea—Epirubicin—hematologic cancer	1.31e-05	5.06e-05	CcSEcCtD
Trazodone—Vomiting—Doxorubicin—hematologic cancer	1.3e-05	5.01e-05	CcSEcCtD
Trazodone—Rash—Doxorubicin—hematologic cancer	1.29e-05	4.97e-05	CcSEcCtD
Trazodone—Dermatitis—Doxorubicin—hematologic cancer	1.29e-05	4.97e-05	CcSEcCtD
Trazodone—Headache—Doxorubicin—hematologic cancer	1.28e-05	4.94e-05	CcSEcCtD
Trazodone—Nausea—Doxorubicin—hematologic cancer	1.22e-05	4.68e-05	CcSEcCtD
Trazodone—HTR2B—Signaling Pathways—NRAS—hematologic cancer	2.75e-06	4.05e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—KRAS—hematologic cancer	2.75e-06	4.04e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—HRAS—hematologic cancer	2.75e-06	4.04e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—FGF2—hematologic cancer	2.75e-06	4.04e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—FGF2—hematologic cancer	2.74e-06	4.03e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PIK3CB—hematologic cancer	2.72e-06	4e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CDKN1B—hematologic cancer	2.72e-06	3.99e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PIK3R1—hematologic cancer	2.71e-06	3.98e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PIK3R1—hematologic cancer	2.71e-06	3.97e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CDKN1B—hematologic cancer	2.7e-06	3.97e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.7e-06	3.97e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—FGF2—hematologic cancer	2.69e-06	3.95e-05	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—AKT1—hematologic cancer	2.69e-06	3.95e-05	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—AKT1—hematologic cancer	2.68e-06	3.93e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CASP3—hematologic cancer	2.66e-06	3.91e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL2—hematologic cancer	2.66e-06	3.91e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—NQO1—hematologic cancer	2.66e-06	3.91e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CD44—hematologic cancer	2.66e-06	3.91e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PIK3R1—hematologic cancer	2.66e-06	3.9e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CASP3—hematologic cancer	2.65e-06	3.89e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—IL6—hematologic cancer	2.65e-06	3.89e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL2—hematologic cancer	2.65e-06	3.89e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MAPK3—hematologic cancer	2.64e-06	3.87e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—JAK2—hematologic cancer	2.64e-06	3.87e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—IL6—hematologic cancer	2.63e-06	3.87e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MAP2K1—hematologic cancer	2.63e-06	3.86e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—JAK2—hematologic cancer	2.63e-06	3.86e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PIK3CD—hematologic cancer	2.61e-06	3.84e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CCND1—hematologic cancer	2.59e-06	3.81e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—JUN—hematologic cancer	2.59e-06	3.8e-05	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—PIK3CA—hematologic cancer	2.59e-06	3.8e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—PIK3CA—hematologic cancer	2.58e-06	3.79e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—JAK2—hematologic cancer	2.58e-06	3.79e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CCND1—hematologic cancer	2.58e-06	3.79e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—PIK3CA—hematologic cancer	2.58e-06	3.79e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—JUN—hematologic cancer	2.58e-06	3.78e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MDM2—hematologic cancer	2.57e-06	3.78e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MDM2—hematologic cancer	2.57e-06	3.77e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MYC—hematologic cancer	2.57e-06	3.77e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TGFB1—hematologic cancer	2.56e-06	3.76e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—KRAS—hematologic cancer	2.56e-06	3.76e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—PIK3CA—hematologic cancer	2.53e-06	3.72e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MDM2—hematologic cancer	2.52e-06	3.7e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYCS—hematologic cancer	2.52e-06	3.7e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CDKN1A—hematologic cancer	2.51e-06	3.69e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PTEN—hematologic cancer	2.5e-06	3.68e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MTOR—hematologic cancer	2.5e-06	3.68e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PIK3CB—hematologic cancer	2.5e-06	3.68e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.5e-06	3.67e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—FGF2—hematologic cancer	2.5e-06	3.67e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PIK3CB—hematologic cancer	2.5e-06	3.67e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MTOR—hematologic cancer	2.5e-06	3.67e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CDKN1A—hematologic cancer	2.5e-06	3.67e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.5e-06	3.67e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PTEN—hematologic cancer	2.49e-06	3.66e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PIK3R1—hematologic cancer	2.47e-06	3.62e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.46e-06	3.61e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MTOR—hematologic cancer	2.45e-06	3.6e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PIK3CB—hematologic cancer	2.45e-06	3.6e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MAPK8—hematologic cancer	2.45e-06	3.6e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—AKT1—hematologic cancer	2.44e-06	3.59e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MAPK8—hematologic cancer	2.44e-06	3.58e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—AKT1—hematologic cancer	2.43e-06	3.57e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—JAK2—hematologic cancer	2.4e-06	3.52e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—HRAS—hematologic cancer	2.39e-06	3.51e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—EP300—hematologic cancer	2.39e-06	3.51e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—HRAS—hematologic cancer	2.38e-06	3.5e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—EP300—hematologic cancer	2.38e-06	3.49e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—KRAS—hematologic cancer	2.37e-06	3.48e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PTEN—hematologic cancer	2.35e-06	3.46e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—PIK3CA—hematologic cancer	2.35e-06	3.45e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CDKN1B—hematologic cancer	2.35e-06	3.45e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CDKN1B—hematologic cancer	2.34e-06	3.44e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MDM2—hematologic cancer	2.34e-06	3.44e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—HRAS—hematologic cancer	2.34e-06	3.44e-05	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—AKT1—hematologic cancer	2.32e-06	3.41e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—SRC—hematologic cancer	2.32e-06	3.41e-05	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—AKT1—hematologic cancer	2.32e-06	3.41e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.32e-06	3.4e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—SRC—hematologic cancer	2.31e-06	3.39e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CASP3—hematologic cancer	2.3e-06	3.38e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CDKN1B—hematologic cancer	2.3e-06	3.38e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL2—hematologic cancer	2.3e-06	3.38e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CASP3—hematologic cancer	2.3e-06	3.37e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL2—hematologic cancer	2.29e-06	3.37e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—IL6—hematologic cancer	2.29e-06	3.36e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—IL6—hematologic cancer	2.28e-06	3.35e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CREBBP—hematologic cancer	2.28e-06	3.35e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MTOR—hematologic cancer	2.28e-06	3.35e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PIK3CB—hematologic cancer	2.28e-06	3.35e-05	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—AKT1—hematologic cancer	2.28e-06	3.34e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—VEGFA—hematologic cancer	2.26e-06	3.32e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CASP3—hematologic cancer	2.25e-06	3.31e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL2—hematologic cancer	2.25e-06	3.31e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—VEGFA—hematologic cancer	2.25e-06	3.3e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—EP300—hematologic cancer	2.24e-06	3.3e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCND1—hematologic cancer	2.24e-06	3.29e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—IL6—hematologic cancer	2.24e-06	3.29e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—STAT3—hematologic cancer	2.24e-06	3.29e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—JUN—hematologic cancer	2.24e-06	3.28e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCND1—hematologic cancer	2.24e-06	3.28e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—NRAS—hematologic cancer	2.23e-06	3.28e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—JUN—hematologic cancer	2.23e-06	3.28e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—STAT3—hematologic cancer	2.23e-06	3.27e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—NRAS—hematologic cancer	2.22e-06	3.26e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.22e-06	3.26e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCND1—hematologic cancer	2.19e-06	3.22e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—JUN—hematologic cancer	2.19e-06	3.22e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—PIK3CA—hematologic cancer	2.18e-06	3.2e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—HRAS—hematologic cancer	2.17e-06	3.19e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CDKN1A—hematologic cancer	2.17e-06	3.18e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	2.16e-06	3.18e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PTEN—hematologic cancer	2.16e-06	3.18e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.16e-06	3.17e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PTEN—hematologic cancer	2.16e-06	3.17e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PTEN—hematologic cancer	2.16e-06	3.17e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.15e-06	3.15e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MAPK3—hematologic cancer	2.14e-06	3.14e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CDKN1B—hematologic cancer	2.14e-06	3.14e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—ALB—hematologic cancer	2.13e-06	3.13e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MAPK3—hematologic cancer	2.13e-06	3.13e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CDKN1A—hematologic cancer	2.12e-06	3.12e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PTEN—hematologic cancer	2.12e-06	3.11e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MAPK8—hematologic cancer	2.12e-06	3.11e-05	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—AKT1—hematologic cancer	2.11e-06	3.11e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MAPK8—hematologic cancer	2.11e-06	3.1e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—AKT1—hematologic cancer	2.11e-06	3.1e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TP53—hematologic cancer	2.11e-06	3.1e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—AKT1—hematologic cancer	2.11e-06	3.09e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PIK3CA—hematologic cancer	2.1e-06	3.09e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.1e-06	3.09e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CASP3—hematologic cancer	2.09e-06	3.08e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL2—hematologic cancer	2.09e-06	3.07e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—IL6—hematologic cancer	2.08e-06	3.06e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MYC—hematologic cancer	2.08e-06	3.06e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	2.08e-06	3.05e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MAPK8—hematologic cancer	2.07e-06	3.04e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MYC—hematologic cancer	2.07e-06	3.04e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—AKT1—hematologic cancer	2.07e-06	3.04e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TGFB1—hematologic cancer	2.06e-06	3.03e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—EP300—hematologic cancer	2.06e-06	3.03e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—EP300—hematologic cancer	2.06e-06	3.02e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—EP300—hematologic cancer	2.06e-06	3.02e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.04e-06	3e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.04e-06	3e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.04e-06	3e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCND1—hematologic cancer	2.04e-06	2.99e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.04e-06	2.99e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—JUN—hematologic cancer	2.03e-06	2.99e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—EP300—hematologic cancer	2.02e-06	2.97e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—HRAS—hematologic cancer	2.01e-06	2.96e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ALB—hematologic cancer	2.01e-06	2.95e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SRC—hematologic cancer	2.01e-06	2.95e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SRC—hematologic cancer	2e-06	2.94e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CDKN1A—hematologic cancer	1.97e-06	2.9e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PTEN—hematologic cancer	1.97e-06	2.89e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SRC—hematologic cancer	1.96e-06	2.89e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	1.95e-06	2.87e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—VEGFA—hematologic cancer	1.95e-06	2.86e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—STAT3—hematologic cancer	1.93e-06	2.84e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—STAT3—hematologic cancer	1.93e-06	2.84e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—NRAS—hematologic cancer	1.93e-06	2.83e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL6—hematologic cancer	1.93e-06	2.83e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NRAS—hematologic cancer	1.93e-06	2.83e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MAPK8—hematologic cancer	1.92e-06	2.83e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.92e-06	2.82e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—KRAS—hematologic cancer	1.92e-06	2.82e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—AKT1—hematologic cancer	1.92e-06	2.82e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	1.91e-06	2.81e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—KRAS—hematologic cancer	1.91e-06	2.81e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	1.89e-06	2.78e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	1.89e-06	2.78e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.88e-06	2.77e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—EP300—hematologic cancer	1.88e-06	2.76e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	1.85e-06	2.71e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MAPK3—hematologic cancer	1.84e-06	2.71e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SRC—hematologic cancer	1.82e-06	2.68e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	1.81e-06	2.66e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.8e-06	2.65e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MYC—hematologic cancer	1.8e-06	2.64e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MYC—hematologic cancer	1.79e-06	2.63e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	1.79e-06	2.63e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TGFB1—hematologic cancer	1.79e-06	2.63e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—AKT1—hematologic cancer	1.78e-06	2.61e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—VEGFA—hematologic cancer	1.78e-06	2.61e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.77e-06	2.61e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	1.77e-06	2.59e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MYC—hematologic cancer	1.76e-06	2.59e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—STAT3—hematologic cancer	1.76e-06	2.59e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PIK3CA—hematologic cancer	1.76e-06	2.58e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	1.76e-06	2.58e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NRAS—hematologic cancer	1.76e-06	2.58e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—AKT1—hematologic cancer	1.72e-06	2.53e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TP53—hematologic cancer	1.71e-06	2.51e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TP53—hematologic cancer	1.7e-06	2.5e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MAPK3—hematologic cancer	1.68e-06	2.47e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—KRAS—hematologic cancer	1.66e-06	2.44e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PIK3CA—hematologic cancer	1.66e-06	2.44e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—KRAS—hematologic cancer	1.66e-06	2.43e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MYC—hematologic cancer	1.64e-06	2.4e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—HRAS—hematologic cancer	1.63e-06	2.4e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TGFB1—hematologic cancer	1.63e-06	2.4e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PTEN—hematologic cancer	1.63e-06	2.39e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	1.63e-06	2.39e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—HRAS—hematologic cancer	1.63e-06	2.39e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL6—hematologic cancer	1.56e-06	2.3e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL6—hematologic cancer	1.56e-06	2.29e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—EP300—hematologic cancer	1.55e-06	2.28e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PTEN—hematologic cancer	1.53e-06	2.25e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	1.53e-06	2.24e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	1.52e-06	2.24e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.52e-06	2.23e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.51e-06	2.22e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—KRAS—hematologic cancer	1.51e-06	2.22e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	1.49e-06	2.19e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TP53—hematologic cancer	1.48e-06	2.17e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TP53—hematologic cancer	1.47e-06	2.16e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—EP300—hematologic cancer	1.46e-06	2.15e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TP53—hematologic cancer	1.45e-06	2.12e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—AKT1—hematologic cancer	1.44e-06	2.12e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—AKT1—hematologic cancer	1.44e-06	2.11e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—HRAS—hematologic cancer	1.41e-06	2.07e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—HRAS—hematologic cancer	1.41e-06	2.07e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.4e-06	2.06e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PIK3CA—hematologic cancer	1.39e-06	2.04e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	1.38e-06	2.03e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—AKT1—hematologic cancer	1.36e-06	1.99e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL6—hematologic cancer	1.35e-06	1.98e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL6—hematologic cancer	1.35e-06	1.98e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TP53—hematologic cancer	1.34e-06	1.97e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.33e-06	1.96e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL6—hematologic cancer	1.32e-06	1.94e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ALB—hematologic cancer	1.31e-06	1.93e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—HRAS—hematologic cancer	1.28e-06	1.89e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.26e-06	1.85e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—AKT1—hematologic cancer	1.25e-06	1.83e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—AKT1—hematologic cancer	1.24e-06	1.83e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—AKT1—hematologic cancer	1.24e-06	1.83e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL6—hematologic cancer	1.23e-06	1.81e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	1.22e-06	1.79e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.16e-06	1.7e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.15e-06	1.69e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AKT1—hematologic cancer	1.13e-06	1.67e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.08e-06	1.59e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PTEN—hematologic cancer	1e-06	1.47e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—EP300—hematologic cancer	9.56e-07	1.4e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—AKT1—hematologic cancer	9.38e-07	1.38e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—AKT1—hematologic cancer	8.84e-07	1.3e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.07e-07	1.04e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—AKT1—hematologic cancer	5.78e-07	8.49e-06	CbGpPWpGaD
